[Drug-induced neutropenia (agranulocytosis)].
Nomura
Takeo
T
Nippon Medical School.
D018926:Anti-Allergic Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000009:adverse effects*; D002491:Central Nervous System Agents / Q000009:adverse effects*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006401:Hematologic Agents / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D009503:Neutropenia / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D013997:Time Factors
D018926:Anti-Allergic Agents; D000890:Anti-Infective Agents; D002317:Cardiovascular Agents; D002491:Central Nervous System Agents; D005765:Gastrointestinal Agents; D006401:Hematologic Agents; D007004:Hypoglycemic Agents; D016179:Granulocyte Colony-Stimulating Factor